Inactive Instrument

News Novartis AG Swiss Exchange

Equities

CH0012005267

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

06-24	Foreign banks target Switzerland after UBS takeover of Credit Suisse	RE
06-24	NOVARTIS AG : Barclays reaffirms its Sell rating	ZD

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Foreign banks target Switzerland after UBS takeover of Credit Suisse	06-24	RE
NOVARTIS AG : Barclays reaffirms its Sell rating	06-24	ZD
INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax	06-23	DP
Factbox-European companies cut jobs as economy sputters	06-21	RE
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15	06-20	DP
Novartis: towards the filing of a buyout offer for MorphoSys	06-20	CF
MorphoSys Set to Delist Following Acquisition by Novartis	06-20	MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis	06-20	MT
Biotech company Morphosys will soon disappear from the stock exchange	06-20	RE
EU regulator mandates label updates on CAR-T cancer therapies	06-14	RE
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	06-14	MT
Nkarta, Inc. Appoints George Vratsanos as Board of Directors	06-13	CI
Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment	06-13	CI
NOVARTIS AG : JP Morgan reiterates its Neutral rating	06-11	ZD
Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	06-07	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	06-07	MT
AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation	06-06	MT
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists	06-06	RE
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06-06	DJ
Novartis and others face Italy antitrust probe over eye drug	06-06	RE